Literature DB >> 5082133

Studies on transfer ribonucleic acid-ribosome complexes. XXI. Effect of antibiotics on peptidyl-puromycin synthesis by mammalian polyribosomes.

S Pestka, H Rosenfeld, R Harris, H Hintikka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5082133

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  10 in total

1.  Inhibitors of protein synthesis V. Irreversible interaction of antibiotics with an initiation complex.

Authors:  C Coutsogeorgopoulos; J T Miller; D M Hann
Journal:  Nucleic Acids Res       Date:  1975-07       Impact factor: 16.971

2.  Effects of synthesis inhibition and nervous activity on concentrations of neuronal substance P.

Authors:  E Winter; P Keen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

3.  Modification of ribosomes in cryptopleurine-resistant mutants of yeast.

Authors:  L Skogerson; C McLaughlin; E Wakatama
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

Review 4.  Antibiotics and compounds affecting tanslation by eukaryotic ribosomes. Specific enhancement of aminoacyl-tRNA binding by methylaxnthines.

Authors:  L Carrasco; C Fernandez-Puentes; D Vazquez
Journal:  Mol Cell Biochem       Date:  1976-02-16       Impact factor: 3.396

5.  Cryptopleurine resistance: genetic locus for a 40S ribosomal component in Saccharomyces cerevisiae.

Authors:  P Grant; L Sánchez; A Jiménez
Journal:  J Bacteriol       Date:  1974-12       Impact factor: 3.490

6.  Cycloheximide resistance of Physarum polycephalum.

Authors:  T E Evans; H H Evans
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

7.  Effect of puromycin analogues and other agents on peptidyl-puromycin synthesis on polyribosomes.

Authors:  S Pestka; R Vince; S Daluge; R Harris
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

8.  Nuclear translation visualized by ribosome-bound nascent chain puromycylation.

Authors:  Alexandre David; Brian P Dolan; Heather D Hickman; Jonathan J Knowlton; Giovanna Clavarino; Philippe Pierre; Jack R Bennink; Jonathan W Yewdell
Journal:  J Cell Biol       Date:  2012-04-02       Impact factor: 10.539

9.  Synthesis and Preclinical Evaluation of a Highly Improved Anticancer Prodrug Activated by Histone Deacetylases and Cathepsin L.

Authors:  Nobuhide Ueki; Wei Wang; Cooper Swenson; Caroline McNaughton; Nicole S Sampson; Michael J Hayman
Journal:  Theranostics       Date:  2016-03-28       Impact factor: 11.556

10.  Elongation inhibitors do not prevent the release of puromycylated nascent polypeptide chains from ribosomes.

Authors:  Benjamin D Hobson; Linghao Kong; Erik W Hartwick; Ruben L Gonzalez; Peter A Sims
Journal:  Elife       Date:  2020-08-26       Impact factor: 8.140
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.